Stock Taper
SCREENER COMPARE ANY 2 STOCKS
AXGN
AXOGEN, INC.
NASDAQ
$51.47
▼ DOWN 0.50% (-0.26)

KEY STATISTICS

Market Cap$2.77 B
52w High$52.91
52w Low$15.24
Dividend Yield22.22%
FrequencySpecial
P/E135.45
Volume772.18K
Shares Out.53.76M

COMPANY

LEADERSHIP

Michael D. Dale
CHIEF EXECUTIVE
Michael D. Dale

COMPENSATION 2026

Salary$775,865
Stock Awards$7,342,895
Incentive Plan Pay$906,133
All Other Comp.$22,561
Total$9,047,454

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 17, 1986
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
622

PRICE TARGET

Target High$60.00
Target Low$48.00
Target Median$53.00
Target Consensus$53.20

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$73.19M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
1994-07-11Forward21:20
1993-07-12Forward21:20
1992-07-10Forward21:20

PRICE

$51.47 ▼ DOWN 0.50% (−$0.26)
OVERLAYS
$51.00$51.30$51.60$51.909:32 AM10:37 AM11:41 AM12:45 PM1:50 PM2:55 PM3:59 PM51.47

About AxoGen, Inc.

https://www.axogeninc.com ↗

AxoGen, Inc. develops and markets surgical nerve repair solutions, including nerve grafts, connectors, protectors, and soft tissue membranes, serving medical professionals worldwide to treat peripheral nerve injuries.

INDUSTRY

Medical - Devices

A PRODUCT AXOGEN, INC. IS KNOWN FOR

Avance® Nerve Graft
Avance® Nerve Graft

Avance® Nerve Graft is an off-the-shelf, biologically active human nerve allograft that facilitates peripheral nerve regeneration without requiring a second surgical site.

COMPETITORS

COMPETITOR
IART COMPARE
MDXG COMPARE
ORGO COMPARE
SYK COMPARE

Revenue by Geography

MapREGIONQ1-2026Q2-2026
UNITED STATES$60.13M $69M ▲
NonUS$1.33M $726K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
140
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 1.6M
IWM
0.08% · 1.4M
XCHA.DE
1.44% · 559.6K
FESM
0.24% · 303.9K
SCHA
0.06% · 253.4K
PSC
0.33% · 176.5K
FYC
0.59% · 164.5K
DFAS
0.05% · 149.7K
PTH
2.39% · 125.4K
DOCT.L
1.92% · 122.4K
R2SC.L
0.09% · 100.9K
USVM
0.29% · 99.3K
NUSC
0.19% · 51.8K
HTEC
1.92% · 29.0K
RSSL
0.09% · 25.1K
GSSC
0.09% · 20.1K
EES
0.06% · 8.5K
AI
AIMS
0.44% · 7.5K
EH
EHLS
0.43% · 4.9K
FSML
0.13% · 3.8K
ESSC
0.28% · 2.3K
URTY
0.03% · 2.1K
SAWS
1.04% · 1.6K
RFLR
0.08% · 1.4K
PQ
PQSG
0.21% · 1.4K
SCDS
0.29% · 549

INSTITUTIONAL OWNERSHIP

SHARES OWNED
57.07%
HOLDERS
353
TOP 12 OF 353 · RANKED BY POSITION SIZE
First Light Asset Management, LLC
5.8M sh · $103.57M
Blackrock, Inc.
4.4M sh · $204.12M
Blackrock Inc.
3.2M sh · $23.53M
Morgan Stanley
3.1M sh · $103.46M
Vanguard Group Inc
2.9M sh · $93.93M
Arrowmark Colorado Holdings LLC
2.0M sh · $34.94M
Wasatch Advisors LP
1.9M sh · $61.53M
Soleus Capital Management, L.P.
1.7M sh · $30.8M
Polar Capital Holdings Plc
1.5M sh · $49.72M
Artemis Investment Management Llp
1.4M sh · $64.52M
Wellington Management Group Llp
1.4M sh · $64.28M
Assenagon Asset Management S.A.
1.4M sh · $45.76M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Donna Shalala
Donna Shalala
Sale (Full)
2019-06-24

INSIDER TRADES

★
OFFICER: EVP & GENERAL COUNSEL
Began Marc A
Purchase · 67.5K shares
2026-08-10
★
DIRECTOR
Wendell Amy McBride
Purchase · 13.4K shares
2026-08-11
★
DIRECTOR
Wendell Amy McBride
Sale · 13.4K shares
2026-08-11
★
OFFICER: EVP & GENERAL COUNSEL
Began Marc A
Sale · 67.5K shares
2026-08-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
MARKET OUTPERFORM 1
OVERWEIGHT 1
OUTPERFORM 1
7 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY Citizens MARKET OUTPERFORM HC Wainwright & Co. BUY Wells Fargo OVERWEIGHT Lake Street BUY Jefferies BUY Raymond James OUTPERFORM

SECTORS PEERS

PEERPRICE
TSHA$5.77COMPARE
TNDM$21.43COMPARE
IART$16.89COMPARE
IRMD$87.07COMPARE
OPK$1.48COMPARE
SANA$3.93COMPARE
INMD$14.85COMPARE
AHCO$5.79COMPARE